Unveiling the Complete Biosynthetic Pathway of Azacitidine: A Rare 1,3,5‐Triazine Nucleoside Derived From GTP
Angewandte Chemie International Edition · 09.11.2026 · 65 (46)
DOI: 10.1002/anie.1881662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 29.09.2026. Verfasst von Dan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Triazines, Azacitidine, Guanosine Triphosphate, Nucleosides. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Municipal Science and Technology Major Project, Shanghai Municipal Commission of Science and Technology, Dongsheng Biotech (Taixing) Co., Ltd..
Abstract (Originalsprache)
Azacitidine is a rare triazine‐containing nucleoside and a clinically used DNA methyltransferase inhibitor for the treatment of myelodysplastic syndromes. Despite its medical importance, its biosynthetic pathway has remained elusive. Herein, we identified the azacitidine biosynthetic gene cluster ( aza BGC) from Streptomyces mobaraensis IPIO2 using a resistance gene‐guided comparative genomics strategy and elucidated its biosynthetic pathway via in vivo and in vitro studies. Unexpectedly, the bifunctional GTP cyclohydrolase I AzaE generates the triaminopyrimidine intermediate as the major product and H2NTP as a shunt product from GTP, diverging from canonical GCHI enzymes. The cofactor‐independent cupin dioxygenase AzaA then assembles the 1,3,5‐triazine scaffold using both O 2 and H 2 O as oxygen donors, a mechanism unprecedented in nucleoside antibiotic biosynthesis. Subsequent decarboxylation by AzaB/AzaC, phosphoribosyl transfer by AzaD, and dephosphorylation by AzaG together with other endogenous hydrolases yield azacitidine. This work uncovers a distinct biosynthetic logic for triazine‐containing nucleosides and provides a molecular basis for the synthetic biology‐driven production of azacitidine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
- College of Life Science, Tarim University, Alar, Xinjiang, China.
- Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Dan Wang, Qingxu Meng, Lingqi Hua, Mengjun Sun, Qianjin Kang, Min-Juan Xu, Linquan Bai
Förderung
- Shanghai Municipal Science and Technology Major Project
- Shanghai Municipal Commission of Science and Technology
- Dongsheng Biotech (Taixing) Co., Ltd.
Zitieren
APA
Wang, D., Meng, Q., Hua, L., Sun, M., Kang, Q., Xu, M. J., & Bai, L. (2026). Unveiling the Complete Biosynthetic Pathway of Azacitidine: A Rare 1,3,5‐Triazine Nucleoside Derived From GTP. Angewandte Chemie International Edition, 65(46). https://doi.org/10.1002/anie.1881662
Vancouver
Wang D, Meng Q, Hua L, Sun M, Kang Q, Xu MJ, et al. Unveiling the Complete Biosynthetic Pathway of Azacitidine: A Rare 1,3,5‐Triazine Nucleoside Derived From GTP. Angewandte Chemie International Edition. 2026;65(46). doi:10.1002/anie.1881662
BibTeX
@article{Wang2026,
author = {Wang, Dan and Meng, Qingxu and Hua, Lingqi and Sun, Mengjun and Kang, Qianjin and Xu, Min-Juan and Bai, Linquan},
title = {Unveiling the Complete Biosynthetic Pathway of Azacitidine: A Rare 1,3,5‐Triazine Nucleoside Derived From GTP},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {46},
doi = {10.1002/anie.1881662}
}
EUVIMED